<https://www.medicalpress.es/#/schema/person/c3b066de771bd45ea7938b0dce9cef55>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/Person>
<https://www.medicalpress.es/mas-de-un-tercio-de-pacientes-con-leucemia-de-alto-riesgo-responden-a-un-nuevo-farmaco-experimental/>